Drug Profile
Research programme: extracellular drug conjugates - Centrose
Latest Information Update: 28 Jul 2016
Price :
$50
*
At a glance
- Originator Wisconsin Alumni Research Foundation
- Developer Centrose; University of Wisconsin System
- Class Cardiac glycosides; Drug conjugates; Monoclonal antibodies; Small molecules
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Colorectal cancer; Non-small cell lung cancer
Most Recent Events
- 28 Jul 2016 No recent reports on development identified - Preclinical for Colorectal cancer and Non-small cell lung cancer in USA (Transdermal)